Organisation of the Body
Help!
|
|
||||
|---|---|---|---|---|---|
| Characteristics of hormone receptors | High affinity for hormone
Hormone specific
Binding is saturatable
🗑
|
||||
| Kds | Binding constant
10^-12 to 10^-9
Very little hormone needed for activation
🗑
|
||||
| EC50 | Conc of hormone that gives 50% response
🗑
|
||||
| Receptor classes | Ligand gated ion channels
G protein coupled receptors
Enzyme linked
Intracellular receptors
🗑
|
||||
| Ligand gated ion channels | Open in response to NTs
Leads to a change in membrane potential due to ion movement
Instantaneous response
🗑
|
||||
| nACRs | 5 protein
2 homodimers and 1 extra protein
Blocked by cobra toxins
Open in response to ACh binding - non-selective cation channel
🗑
|
||||
| Katp channel | Glucose enters beta cells and is metabolised to produce ATP
This binds to K channels and blocks them
Leads to depolarisation and Ca influx
Insulin release triggered
ATP acts as a hormone
🗑
|
||||
| G protein coupled receptors | Hormone binds to receptor leading to G protein mobilisation
They interact with enzymes through a second messenger system
Timescale - seconds/minutes
🗑
|
||||
| What activates GPCRs | Protein hormones - glucagon
Amines - adrenaline
Lipids - prostaglandins
🗑
|
||||
| Family of GPCRs | Around 820 in the human body
All have similar structures - hard to design drugs specific to one, so unwanted effects are common
🗑
|
||||
| Structure of GPCRs | 7 transmembrane regions
Extracellular N-terminus
Often post translationally glycosylated and phosphorylated to regulate activity
🗑
|
||||
| M2 muscarinic receptors | Found in the heart - slow heart rate
QNB - antagonist
🗑
|
||||
| G proteins | Get their name from their ability to bind GTP and GDP
They exist in an active GTP bound and an inactive GDP bound form
Active G proteins bind and activate signalling enzymes causing a specific response
Heterotrimeric - alpha, beta and gamma subunits
🗑
|
||||
| Types of GPCRs | Gq - activates PLC
Gi - inhibits adenylate cyclase
Gs - stimulates adenylate cyclase
G12/13 - Rho family
Gb - activates inwardly rectifying potassium channels
🗑
|
||||
| The G protein cycle | Inactive - loosly associated with proteins
Ligand binds and recruits G proteins
GTP exchange causes dissociation of the protein
Subunits have different effects
GTP hydrolysis causes reassociation
🗑
|
||||
| Downstream effectors of GPCRs | Adenylate cyclase
Phospholipase C
Ion channels
🗑
|
||||
| Adenylate cyclase | Stimulated by Gs and inhibited by Gi
Converts ATP into cAMP
This activates PKA by releasing its catalytic subunits
cAMP degraded by phosphodiesterase
🗑
|
||||
| Effects of Cholera | A GPCR agonist
Binds to Gs - increased cAMP and PKA
Activates CTFR
Overactive CTFR causes Cl loss into lumen of gut followed by Na and water
Leads to internal dehydration
Enkephalin - stimulates Gi to reduce effects
🗑
|
||||
| cAMP in steroid synthesis | ACTH stimulates Gs - cAMP produced
Immediately upregulated cholesterol synthesis by cholesterol ester hydrolase
Over a few hours allows uptake of cholesterol by mitochondria
🗑
|
||||
| PLC | Activated by Gq receptors
Cleaves PIP2 into DAG and IP3
DAG activates PKC - phosphorylates proteins
IP3 activates store operated calcium ion channels leading to Ca efflux from SR - activation of intracellular proteins
🗑
|
||||
| Role of Gq/Gs switch in beta cells | Normal B cells us a Gs pathway to secrete insulin involving GIP and GLP-1
Following chronic hyperglycemia and chronic sulfonylurea treatment they switch to Gq
🗑
|
||||
| Ion channels in GPCR | Channels phosphorylated - less active
e.g. G protein gated inwardly rectifying potassium channels in the heart
🗑
|
||||
| Smooth muscle contraction | Uses multiple mechanisms
Ligand gated ion channels
Voltage gated ion channels
Gq proteins - IP3 activates Ryr channels
🗑
|
||||
| Amplification | Reaction cascades cause massive signal amplification
Proteins made can last a long time, so short activation affects function for longer periods
🗑
|
||||
| Enzyme linked channels | Receptor is also the effector enzyme
e.g. tyrosine cyclase enzyme activity
Receptors dimerise on ligand binding
Autophosphorylation at tyrosine and serine residues
🗑
|
||||
| Insulin receptor | Tyrosine kinase receptor
Leads to insertion of Glut4 into cell membranes
Under fasting conditions no insulin = no glucose uptake as no Glut4 channels in membrane
🗑
|
||||
| Intracellular receptors | Control of DNA transcription
e.g. steroid hormones and Vit D (for Ca uptake)
Takes hours for proteins to be produced
🗑
|
||||
| Steroid receptor structure | DNA strand contains specific hormone response elements
Contains regions for transcriptional regulation, DNA binding and hormone binding
🗑
|
||||
| What binds to intracellular receptors | Androgens
Estrogen
Progesterone
Glucocorticoids
Mineralocorticoids
Thyroid hormone
Vit D
🗑
|
||||
| Turning off the signal | Removal or degradation of the hormone
Desensitisation of the receptor
Internalisation of the receptor
🗑
|
||||
| Desensitisation of GPCRs | Phosphorylation of certain residues at the C terminus by GRK
Arrestin binds to the receptor and prevents G protein interaction
🗑
|
||||
| Resensitisation | Phosphatases remove the phosphate from the C terminus
Causes arrestin to dissociate
🗑
|
||||
| Role of phosphodiesterase's in glucose control | Serves as a connection between glucagon and insulin pathways
Insulin drives activation of phosphodiesterase to downregulate the role of glucagon
Breaks down cAMP
🗑
|
||||
| Receptor internalisation | Receptors taken into the cell by endocytosis
Basically receptor mediated endocytosis
Dopamine D1 receptors are permanently downregulated due to overuse in addiction - via internalisation and DNA metylation
🗑
|
||||
| What causes disease at receptors | Failure of ligand binding
Failure of signal transduction
Constitutively active signal receptor systems
Antibodies to receptor
🗑
|
||||
| Inactivating receptor mutations | Receptor does not function despite hormone present
🗑
|
||||
| Activating receptor mutations | Receptor continually active without hormone bound
🗑
|
||||
| Dwarfism | Due to growth hormone releasing hormone inactivating receptor mutations
No signalling - reduced growth hormone release
No long bone or muscle growth
Treated by administering growth hormone
🗑
|
||||
| Activating receptor mutations | Precocious puberty - puberty starting at 5-9 years
Constant activation of LH receptors without the presence of the hormone
Ovary - estrogen
Testes - testosterone
🗑
|
||||
| Physiological response to receptor activation | Vesicle fusion
Gene transcription
Protein production
🗑
|
||||
| Types of cell signalling | Depolarisation induced - Ca entry dependant
Depolarisation independent - Ca entry dependant
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
12345678987654321000000
Popular Medical sets